CD274 and neoplasm: The finding that several members of T cell activation pathway are downregulated in different T stages in OSCC indicates that T cell response is impaired either by the downregulation of important genes in this pathway, or even by the higher expression of PD-L1, causing an important reduction in T cell anti-tumor response.